TwinStrand DuplexSeqTM assays can help you identify AML-related mutations with 100-fold higher resolution than standard NGS
Want to learn more about how our duplex sequencing can advance your AML MRD research?
The TwinStrand DuplexSeqTM AML-29 MRD assay leverages duplex sequencing technology for high sensitivity detection of ultra-low frequency mutations across 29 genes associated with adult acute myeloid leukemia (AML).
Our Data Sheet details the performance specifications for our DuplexSeq assay that enables consistent sub-1/10,000 variant allele frequency detection.
We Hope You Enjoyed ASH 2022!
Interested in bringing TwinStrand DuplexSeqTM assays into your lab?
Learn more about our AML panel covering 29 genes recurrently mutated in Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), & Clonal Hematopoiesis (CHIP)
Contact us to discuss our custom panel services
Use CODE “ASH2022” to take advantage of our BOGO 50% kit promotion through January 31, 2023
